By Sean Farrell
Date: Wednesday 18 Nov 2020
(Sharecast News) - PureTech Health said its LYT-100 inflammation and fibrosis treatment showed good tolerability and that it would test its effectiveness on long-Covid symptoms.
By Sean Farrell
Date: Thursday 27 Aug 2020
(Sharecast News) - PureTech Health's first-half loss narrowed as revenue increased and the biotechnology company's expenses fell due to disposals of investments.
By Duncan Ferris
Date: Tuesday 27 Aug 2019
(Sharecast News) - PureTech Health reported a dip in interim revenue on Tuesday as lower grant revenue dragged income lower and resulted in a deepened operating loss.
Thursday broker round-up | 13-Jun-2019 | ShareCast |
PureTech Health's Karuna raises $68m in series B... | 18-Mar-2019 | ShareCast |
Currency | UK Pounds |
Share Price | 139.80p |
Change Today | 0.018p |
% Change | 1.30 % |
52 Week High | 238.50p |
52 Week Low | 101.60p |
Volume | 4,731 |
Shares Issued | 237.39m |
Market Cap | £331.87m |
Strong Buy | 2 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
Time | Volume / Share Price |
16:29 | 39 @ 139.80p |
16:21 | 124 @ 139.20p |
16:20 | 351 @ 139.60p |
16:02 | 35 @ 139.20p |
15:47 | 1 @ 138.80p |
Chair | Raju Kucherlapati |
CEO | Bharatt Chowrira |
You are here: research